The availability of several, large-scale, short hairpin RNA (shRNA) and small interfering RNA (siRNA) screens [20–23], conducted in multiple tumour cell lines (TCLs), some of which are derived from TNBCs, now make a detailed identification of highly penetrant RB1-related synthetic lethal effects now possible. This evidence concerns the gene RB1 and neoplasm.